Clinical value of calcitonin and carcinoembryonic antigen doubling times in medullary thyroid carcinoma.
暂无分享，去创建一个
[1] S. Baylin,et al. Cytogenetic studies of a human medullary thyroid carcinoma cell line. , 1987, Cancer genetics and cytogenetics.
[2] A. Tashjian,et al. Localization of residual medullary thyroid cancer by thallium/technetium scintigraphy. , 1985, Surgery.
[3] M. Saad,et al. Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid. , 1984, The Journal of clinical endocrinology and metabolism.
[4] A. Miyauchi,et al. Relation of Doubling Time of Plasma Calcitonin Levels to Prognosis and Recurrence of Medullary Thyroid Carcinoma , 1984, Annals of surgery.
[5] J. Mulvihill. Research vistas in the multiple endocrine neoplasia syndromes. , 1984, Henry Ford Hospital medical journal.
[6] R. Norum,et al. Clinical value of tumor doubling estimations in multiple endocrine neoplasia type II. , 1984, Surgery.
[7] M. Tubiana,et al. The values of calcitonin and carcinoembryonic antigen in the treatment and management of nonfamilial medullary thyroid carcinoma , 1983, Cancer.
[8] E. Kim,et al. Carcinoembryonic antigen radioimmunodetection in the evaluation of colorectal cancer and in the detection of occult neoplasms. , 1983, Gastroenterology.
[9] S. Lippman,et al. The prognostic and biological significance of cellular heterogeneity in medullary thyroid carcinoma: a study of calcitonin, L-dopa decarboxylase, and histaminase. , 1982, The Journal of clinical endocrinology and metabolism.